Concepedia

Hovis Imade

HI

Statistics

Publications

9

Citations

358

H-Index

9

Active since

2001

Affiliations

Abbott Fund(Current)

Abbott (United States)

Discovery Laboratories (United States)

Hovis Imade is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

2001–2006

9

Publications

9

Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-<i>N</i>-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Jeffrey J. Rohde, Marina Pliushchev, Bryan K. Sorensen et al. · Journal of Medicinal Chemistry · 2006 · 77 citations · Full text

, , +16

Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors

Bryan K. Sorensen, Martin Winn, Jeff Rohde et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 64 citations · Full text

, , +3

Novel sulfonate analogues of combretastatin A-4

Stephen L. Gwaltney, Hovis Imade, Kenneth J. Barr et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 53 citations · Full text

, , +8

Discovery of adamantane ethers as inhibitors of 11β-HSD-1: Synthesis and biological evaluation

Jyoti Patel, Shuai Qi, Jürgen Dinges et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 41 citations · Full text

, , +9

Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives

Stephen L. Gwaltney, Stephen J. O’Connor, Lissa T.J. Nelson et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 34 citations · Full text

, , +9

1–5 of 9